Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
about
Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s LymphomaHow I treat HIV-associated lymphomaNewly emerging therapies targeting viral-related lymphomas.Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphomaClinical analysis of 10 AIDS patients with malignant lymphoma.Central nervous system involvement in AIDS-related lymphomasHuman immunodeficiency virus - associated lymphomas: a neglected domain.Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South AfricaTreatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.Lung Malignancies in HIV Infection.Clinical Analysis of Five Cases of AIDS-related Non-Hodgkin Lymphoma.Therapeutic options for HIV-associated lymphomas.Stem cell transplantation for lymphoma patients with HIV infection.Eleven years of experience with AIDS-related lymphomas at the Institute of Oncology Ljubljana.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Clinical management of HIV-associated hematologic malignancies.Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.Sustained favourable HIV viral load response in South African patients during concomitant HAART and cancer therapy.Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study.Raltegravir-based HAART regimen in a patient with large B-cell lymphoma.Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study.A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma.Complete regression of early diffuse B-cell lymphoma in an HIV-positive patient on antiretroviral therapy alone.Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034.Guidelines for the management of diffuse large B-cell lymphoma.
P2860
Q24240190-11018061-25CD-4960-9EC8-34806243AA05Q26821860-7F74B0BB-2C2D-4A2A-87D9-7031F6DE72DEQ33699201-4CEB34FF-1F11-4B46-8DEF-CED5CE366DC8Q33806007-49A76355-9653-4914-86E4-C817DFDB1DD3Q35848330-7ADA8426-2520-4A13-A63D-76FC04D3FC83Q36814344-1E303519-0E78-4181-9557-D3C1950B222FQ36989459-9D709206-4E1F-45E3-891E-753D9D7FACFCQ37137151-B6A94935-2679-41A8-B528-AB3A247EDFD9Q37231689-8384F731-9B66-4E05-9B42-59B42E64261AQ37291598-BF3A724F-AEC7-4AC2-A1A7-6FB403E4460FQ37478443-E876EF91-5CBF-4528-93AD-025651BF5345Q37563265-BF7C1B86-2607-4037-A415-1682D96DA6CBQ37781368-7DA3E389-CDDD-4481-B4BA-8D5FC6207406Q37793405-A38DB1F9-B1AC-4C37-8EEC-1571019BC8CBQ37868477-E8473AC0-FE2B-4CE8-BF3E-A9FB2E910AE3Q38194845-CCDAAE99-E84A-4B37-86C9-E5E9EECD27D2Q38210131-00126005-6115-4384-90BC-C79E33A1F585Q38664912-9A31F029-F302-40DD-9D67-906667E5E1D5Q41919568-A1A1E251-C3C5-4BBA-A3E5-54224F36DB6FQ41989689-DEC69061-6F4D-4744-B01F-A633831EF002Q42181272-22EAECBB-6952-45BB-AF53-C1C2F6A00959Q42197959-E6A3A1C6-E5FF-4893-8C2F-7BE0B0F10BE7Q42235915-B273A037-0EFA-4080-9DD3-CDF5FED23768Q42264979-119BD292-B6C5-49E8-B06E-7B6EC562D3A9Q43205348-63F87544-8573-456D-995C-83A49DDC04BDQ43706654-3CF2F573-3211-46DF-BC09-1F2D8379E09CQ43752446-06AE0FF6-C7DC-4ACE-82DF-A22420AAEC90Q46455262-7EBBD5C2-785D-44E5-B57C-760B75636DF8Q47436144-A974419B-ED70-402C-AF05-D6F036AF121FQ54708579-AE37465F-BB3F-47B9-94E3-554BF14E615C
P2860
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Safety and efficacy of cycloph ...... : results of a phase II trial.
@en
Safety and efficacy of cycloph ...... : results of a phase II trial.
@nl
type
label
Safety and efficacy of cycloph ...... : results of a phase II trial.
@en
Safety and efficacy of cycloph ...... : results of a phase II trial.
@nl
prefLabel
Safety and efficacy of cycloph ...... : results of a phase II trial.
@en
Safety and efficacy of cycloph ...... : results of a phase II trial.
@nl
P2093
P50
P1476
Safety and efficacy of cycloph ...... a: results of a phase II trial
@en
P2093
Andres López
Armando López-Guillermo
Eugenia Abella
Josep-Maria Ribera
Marta García
PETHEMA, GELTAMO, GELCAB and GESIDA Groups
Pilar Miralles
Santiago Gardella
P304
P356
10.1111/J.1365-2141.2007.06943.X
P407
P577
2007-12-19T00:00:00Z